Revolade 25® Eltrombopag Tablets

Revolade 25 mg contains eltrombopag, a medicine used to increase platelet counts in selected patients with immune thrombocytopenia (ITP), chronic hepatitis C-related thrombocytopenia and severe aplastic anaemia, depending on the approved indication.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.